Streetbeat News

Analyst Ratings

NVEI

Over the past 3 months, 8 analysts have published their opinion on Nuvei (NASDAQ:NVEI) stock. The company has an average price target of $29.12, representing a 38.54% decrease from the previous average price target of $47.38. The analysts' ratings range from bullish to indifferent.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 4:00 pm

COUR

Cantor Fitzgerald analyst Brett Knoblauch has reiterated an Overweight rating on Coursera (NYSE:COUR) and maintained a $17 price target.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 4:00 pm

WOLF

Over the past 3 months, 11 analysts have published their opinion on Wolfspeed (NYSE:WOLF) stock. The average price target is $58.55, implying an upside from the current price of $41.14. This represents a 11.95% decrease from the previous average price target of $66.50.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 4:00 pm

CPE

Over the last quarter, Callon Petroleum (NYSE:CPE) has received 4 bullish, 2 somewhat bullish, and 3 indifferent analyst ratings. The company's average 12-month price target is $48.44, an increase of 2.52% from the previous average of $47.25. No bearish ratings were observed.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 4:00 pm

AVPT

Cantor Fitzgerald analyst Brett Knoblauch has reiterated an Overweight rating on AvePoint (NASDAQ:AVPT) and maintained a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:59 pm

ZLAB

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Zai Lab (NASDAQ:ZLAB) and maintained a $70 price target.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:59 pm

TSLA

Goldman Sachs has lowered its EPS estimates for Tesla for 2023 and 2024, primarily due to lower average selling prices (ASPs). This has led to a decrease in Tesla's share price.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:58 pm

MLTX

Cantor Fitzgerald analyst Prakhar Agrawal has reiterated an Overweight rating on MoonLake (NASDAQ:MLTX) and maintained a $65 price target.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:57 pm

JNJ

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Johnson & Johnson (NYSE:JNJ) and maintained a price target of $215.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:57 pm

IMVT

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Immunovant (NASDAQ:IMVT) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:56 pm